Literature DB >> 16307278

In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis.

Simona Inghilleri1, Patrizia Morbini, Tiberio Oggionni, Sergio Barni, Carla Fenoglio.   

Abstract

Reactive oxygen species (ROS) and nitric oxide (NO) have a role in the development of pulmonary fibrosis after bleomycin administration. The ROS production induces an antioxidant response, involving superoxide dismutases (SODs), catalase, and glutathione peroxidases. We compared in situ oxidative burden and antioxidant enzyme activity in bleomycin-injured rat lungs and normal controls. ROS expression and catalase, glucose-6-phosphate-dehydrogenase (G6PHD), and NOS/NADPH-diaphorase activity were investigated by using histochemical reactions. Nitric oxide synthase (e-NOS and i-NOS) and SOD (MnSOD, Cu/ZnSOD, ECSOD) expression was investigated immunohistochemically. After treatment ROS production was enhanced in both phagocytes and in type II alveolar epithelial cells. Mn, Cu/Zn, and ECSOD were overexpressed in parenchymal cells, whereas interstitium expressed ECSOD. Catalase and G6PHD activity was moderately increased in parenchymal and inflammatory cells. NOS/NADPH-d activity and i-NOS expression increased in alveolar and bronchiolar epithelia and in inflammatory cells. It can be suggested that the concomitant activation of antioxidant enzymes is not adequate to scavenge the oxidant burden induced by bleomycin lung damage. Inflammatory cells and also epithelial cells are responsible of ROS and NO production. This oxidative and nitrosative stress may be a substantial trigger in TGF-beta1 overexpression by activated type II pneumocytes, leading to fibrotic lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307278     DOI: 10.1007/s00418-005-0116-7

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  47 in total

Review 1.  Lung inflammation and fibrosis.

Authors:  P A Ward; G W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

2.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis.

Authors:  A M Cantin; R C Hubbard; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1989-02

3.  Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis.

Authors:  G Borzone; R Moreno; R Urrea; M Meneses; M Oyarzún; C Lisboa
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

4.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Venerino Poletti; Alberto Zamò; Maurizio Lestani; Licia Montagna; Paola Piccoli; Serena Pedron; Manuela Bertaso; Aldo Scarpa; Bruno Murer; Alessandra Cancellieri; Roberta Maestro; Gianpietro Semenzato; Claudio Doglioni
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

Authors:  R Ziesche; E Hofbauer; K Wittmann; V Petkov; L H Block
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

6.  Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.

Authors:  Zeki Yildirim; Yusuf Turkoz; Mahir Kotuk; Ferah Armutcu; Ahmet Gurel; Mustafa Iraz; Suleyman Ozen; Ismet Aydogdu; Omer Akyol
Journal:  Nitric Oxide       Date:  2004-09       Impact factor: 4.427

7.  Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias.

Authors:  K Kuwano; N Nakashima; I Inoshima; N Hagimoto; M Fujita; M Yoshimi; T Maeyama; N Hamada; K Watanabe; N Hara
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

8.  Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis.

Authors:  K Zhang; K C Flanders; S H Phan
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

9.  Superoxide released from neutrophils causes a reduction in nitric oxide gas.

Authors:  K L Jones; T W Bryan; P A Jinkins; K L Simpson; M B Grisham; M W Owens; S A Milligan; B A Markewitz; R A Robbins
Journal:  Am J Physiol       Date:  1998-12

10.  Expression of nitric oxide synthase, aquaporin 1 and aquaporin 5 in rat after bleomycin inhalation.

Authors:  An-Soo Jang; Jong-Un Lee; Inseon-S Choi; Kyung-Ok Park; June Hyuk Lee; Sung-Woo Park; Choon-Sik Park
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

View more
  19 in total

1.  Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.

Authors:  Zachary Van Rheen; Cheryl Fattman; Shannon Domarski; Susan Majka; Dwight Klemm; Kurt R Stenmark; Eva Nozik-Grayck
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-10       Impact factor: 6.914

2.  Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses.

Authors:  Neelam Azad; Anand Krishnan V Iyer; Liying Wang; Yuxin Liu; Yongju Lu; Yon Rojanasakul
Journal:  Nanotoxicology       Date:  2012-01-20       Impact factor: 5.913

3.  Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats.

Authors:  Hilal Ermis; Hakan Parlakpinar; Gazi Gulbas; Nigar Vardi; Alaadin Polat; Asli Cetin; Talat Kilic; Zeynep Ayfer Aytemur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-08-31       Impact factor: 3.000

Review 4.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

Review 5.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

6.  Region-specific role for Pten in maintenance of epithelial phenotype and integrity.

Authors:  Per Flodby; Janice M Liebler; Mitsuhiro Sunohara; Dan R Castillo; Alicia M McConnell; Manda S Krishnaveni; Agnes Banfalvi; Min Li; Barry Stripp; Beiyun Zhou; Edward D Crandall; Parviz Minoo; Zea Borok
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-18       Impact factor: 5.464

7.  Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

Review 8.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

9.  Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity.

Authors:  Ayumi Yoshizaki; Kazuhiro Komura; Yohei Iwata; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato
Journal:  J Clin Immunol       Date:  2008-09-30       Impact factor: 8.317

10.  Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice.

Authors:  Anna A Shvedova; Elena R Kisin; Ashley R Murray; Olga Gorelik; Sivaram Arepalli; Vincent Castranova; Shih-Hong Young; Fei Gao; Yulia Y Tyurina; Tim D Oury; Valerian E Kagan
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-27       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.